Pretimectal (trimetazidine dihydrochloride) is intended for use in adult patients, in combination with other medicines to treat angina pectoris (chest pain caused by coronary disease).


Pretimectal is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Subject to medical prescription.

Concentration and pharmaceutical form: 35 mg modified-release tablets